In the ALD cohort, association of liver cirrhosis remained significant also after further adjusting for risk variants of other well-established ALD genetic modifiers (PNPLA3, TM6SF2 and MBOAT7). This evidence concerns the gene TM6SF2 and cirrhosis of liver.